News

AstraZeneca (LSE:AZN) Announces Positive Results From Breztri Trials For Uncontrolled Asthma
AstraZeneca (LSE:AZN) recently announced phase III trial results for Breztri Aerosphere, its triple-combination asthma ...
Applied Clinical Trials Online14h
AstraZeneca’s Breztri Meets Primary Endpoints in Duo of Phase III Asthma Trials
The single-inhaler demonstrated a meaningful improvement in lung function in the Phase III KALOS and LOGOS studies.
Fierce Pharma3d
AstraZeneca's Breztri aces 2 asthma trials, lining it up for label expansion
AstraZeneca has taken a key step in advancing Breztri Aerosphere toward a potential label expansion and achieving its goal of ...
AstraZeneca's Triple-Combination Therapy Breztri Hits Primary Goals In Two Pivotal Studies For Asthma
AstraZeneca Plc (NASDAQ:AZN) reported topline data from Phase 3 KALOS and LOGOS trials in patients with uncontrolled asthma.
Medical Dialogues2d
AstraZeneca Breztri met primary endpoints in Phase III trials in asthma
AstraZeneca has announced the Positive high-level results from the Phase III KALOS and LOGOS trials in patients with ...
AstraZeneca's Breztri meets all primary endpoints in asthma trials
AstraZeneca announced on Friday that its inhaled triple-combination therapy ‘Breztri Aerosphere’ met all primary endpoints in ...
AstraZeneca's 'smoker's lung' therapy meets main goals of late-stage asthma trials
AstraZeneca said on Friday its triple-combination inhaler Breztri Aerosphere met all main goals in two late-stage trials for ...
Stocktwits on MSN3d
AstraZeneca’s Breztri Therapy Meets Primary Goals In Late-Stage Trials To Treat Asthma: Retail’s Positive
AstraZeneca (AZN) said on Friday that it received positive results from two late-stage trials for its triple-combination ...
London South East3d
AstraZeneca's Breztri meets all primary endpoints in asthma trials
(Sharecast News) - AstraZeneca announced on Friday that its inhaled triple-combination therapy 'Breztri Aerosphere' met all primary endpoints in two phase three trials, delivering statistically ...
pharmaphorum3d
Trials set up filings for AZ's triple therapy in asthma
AstraZeneca's three-drug inhaler Breztri Aerosphere has shown efficacy for uncontrolled asthma in a pair of phase 3 trials ...
Reuters4d
AstraZeneca's 'smoker's lung' therapy meets main goals of late-stage asthma trials
May 2 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Friday its triple-combination inhaler Breztri Aerosphere met all main goals in two late-stage trials for uncontrolled asthma ...